Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Nov;110(3):368-75.
doi: 10.1046/j.1365-2567.2003.01748.x.

Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice

Affiliations

Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice

Sukumar Pal et al. Immunology. 2003 Nov.

Abstract

To establish the feasibility of inducing a protective immune response against a chlamydial genital infection in animals with different genetic backgrounds, groups of C3H/HeN (H-2k), BALB/c (H-2d) and C57BL/6 (H-2b) mice, were immunized intranasally with elementary bodies (EB) of the Chlamydia trachomatis mouse pneumonitis biovar. Following the intranasal immunization strong Chlamydia-specific humoral and cell-mediated immune (CMI) responses were detected in the three strains of mice. Eight weeks following immunization the animals were challenged with C. trachomatis in the genital tract. Vaginal cultures showed that the three strains of mice immunized with EB were significantly protected in comparison to the sham immunized animals. To determine the ability of this immunization protocol to protect against infertility six weeks after the genital challenge the animals were mated. Mice of the three strains immunized with EB showed significant protection as demonstrated by the number of animals that were fertile, and the number of embryos present in their uterine horns, in comparison to the sham immunized mice.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunoblot of serum samples using C. trachomatis MoPn EB as the antigen performed on a 5–20% gradient SDS–PAGE. Lane 1, MW markers (×1000). Lanes 2, 3, and 4, preimmunization serum samples from C3H/HeN, C57BL/6 and BALB/c mice, respectively. Lanes 5, 6 and 7 serum samples collected 8 weeks after i.n. immunization from C3H/HeN, C57BL/6 and BALB/c mice, respectively. Lane 8, monoclonal antibodies against the 150 000 MW, the 60 000 MW crp, MOMP and the 28 000 MW proteins of the C. trachomatis MoPn serovar.

References

    1. Grayston JT, Wang SP. New knowledge of Chlamydiae and the diseases they cause. J Infect Dis. 1975;132:87–105. - PubMed
    1. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Human Reprod Update. 1999;5:433–47. - PubMed
    1. Schachter J. Infection and disease epidemiology. In: Stephens RS, editor. Chlamydia: Intracellular Biology, Pathogenesis, and Immunity. Washington, DC: ASM Press; 1999. pp. 139–69.
    1. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, et al., editors. Sexually Transmitted Diseases. New York: McGraw-Hill; 1999. pp. 407–22.
    1. Cates W and the American Social Health Association Panel. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. Sex Transm Dis. 1999;26:S2–7. - PubMed

Publication types

MeSH terms